What is Atofil?
Atofil operates as a comprehensive, turnkey solution provider for the nutraceutical and supplement industry, specializing in the end-to-end design and production of labels, logos, and promotional materials. By integrating rigorous FDA compliance standards into its design workflow, the company mitigates regulatory risk for its clients, ensuring that all packaging meets stringent federal requirements. Their market position is defined by a focus on high-quality, compliant branding that addresses the critical seven-second window of consumer decision-making. While currently focused on solid-dose supplement packaging, the firm is actively evaluating the expansion of its service portfolio to include liquid supplement solutions, further diversifying its operational footprint.
How much funding has Atofil raised?
Atofil has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Atofil
PPP
Public-Private Partnership
What's next for Atofil?
With the infusion of this late-stage capital, Atofil is poised to accelerate its strategic growth initiatives. The primary focus will likely involve the expansion of its manufacturing capabilities to accommodate the anticipated launch of liquid supplement packaging services. Furthermore, the company is expected to deepen its integration with legal and regulatory partners to maintain its competitive edge in compliance-heavy markets. By leveraging this financial backing, Atofil aims to streamline its supply chain and enhance its digital marketing infrastructure, ensuring that it remains the preferred partner for brands seeking both aesthetic excellence and regulatory security in an increasingly complex consumer landscape.
See full Atofil company page
